Eventide Asset Management, LLC Annexon, Inc. Transaction History

Eventide Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.74 - $7.46 $6.58 Million - $13.1 Million	-1,759,258 Reduced 48.51%	1,867,250 $7.19 Million
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $2.12 Million - $9.27 Million	776,508 Added 27.25%	3,626,508 $9.9 Million
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $3.66 Million - $7 Million	318,372 Added 12.58%	2,850,000 $32.7 Million
Q3 2021 Nov 15, 2021	BUY	$16.35 - $23.4 $2 Million - $2.87 Million	122,462 Added 5.08%	2,531,628 $47.1 Million
Q2 2021 Aug 16, 2021	BUY	$17.81 - $27.48 $7.21 Million - $11.1 Million	404,550 Added 20.18%	2,409,166 $53.3 Million
Q4 2020 Feb 16, 2021	BUY	$20.81 - $30.55 $4.82 Million - $7.07 Million	231,505 Added 13.06%	2,004,616 $49.2 Million
Q3 2020 Nov 13, 2020	BUY	$17.5 - $30.23 $31 Million - $53.6 Million	1,773,111 New	1,773,111 $52.4 Million

158

102M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $315M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.